Preliminary research show conolidine might inhibit distinct ion channels, cutting down neuronal excitability and limiting suffering alerts. This system is particularly suitable in neuropathic agony, where by abnormal signaling results in persistent pain. Also, conolidine seems to influence G protein-coupled receptor (GPCR) pathways integral to suff